Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to millions of adults with obesity in the U.S., though the plan would likely face opposition under President-elect Donald Trump's second administration.

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr. may not be such a fan.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.

Doctors recommend that people on weight-loss drugs try to avoid foods that are slathered in butter or sugar. So opt for the green beans with almond slivers over the dense green bean casserole and perhaps consider the homemade cranberry sauce over the canned variety.

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.

Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."

Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of Americans.

The Biden administration wants to expand access to popular weight loss drugs like Wegovy and Ozempic. The new proposal would allow millions of obese Americans covered by Medicaid and Medicare to be eligible for the drugs.